Blogs & News
hyperCORE International 's Vaccine Capabilities
Experience and Quality
hCI contributed an estimated 10% of subjects towards the Pfizer and Moderna COVID-19 vaccine trials.
44 PIs with vaccine experience.
Conducted over 400 vaccine trials.
Lab capabilities include PBMC and IBC certified.
Access to and success with enrolling large numbers of special populations including healthy, diverse, elderly, pediatric, and those with co-morbidities.
60% of labs have BioSafety Level 2.
Ability to scale quickly to accommodate large volume trials using shared resources and platforms.
One Network for One Trial Solution
Single Contract and Centralized Budget
All Sites Virtual Trial Certified
Virtual /Telemedicine/100% Paper less System
Remote and Mobile Units Available.
Multiple Hospital Affiliations
100 Locations Across North and South America
Vaccine enrollment metrics
Input your search keywords and press Enter.